237 related articles for article (PubMed ID: 33846482)
1. Carbohydrate binding module-fused antibodies improve the performance of cellulose-based lateral flow immunoassays.
Elter A; Bock T; Spiehl D; Russo G; Hinz SC; Bitsch S; Baum E; Langhans M; Meckel T; Dörsam E; Kolmar H; Schwall G
Sci Rep; 2021 Apr; 11(1):7880. PubMed ID: 33846482
[TBL] [Abstract][Full Text] [Related]
2. Point of care detection of SARS-CoV-2 antibodies and neutralisation capacity-lateral flow immunoassay evaluation compared to commercial assay to inform potential role in therapeutic and surveillance practices.
McGrath J; O'Doherty L; Conlon N; Dunne J; Brady G; Ibrahim A; McCormack W; Walsh C; Domegan L; Walsh S; Kenny C; Allen N; Fleming C; Bergin C
Front Public Health; 2023; 11():1245464. PubMed ID: 37841735
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of six immunoassays for the detection of antibodies against SARS-CoV-2.
Pérez-García F; Pérez-Tanoira R; Iglesias ME; Romanyk J; Arroyo T; Gómez-Herruz P; González R; Lapeña García S; Cuadros-González J
J Virol Methods; 2021 Mar; 289():114047. PubMed ID: 33338544
[TBL] [Abstract][Full Text] [Related]
4. Four point-of-care lateral flow immunoassays for diagnosis of COVID-19 and for assessing dynamics of antibody responses to SARS-CoV-2.
Wu JL; Tseng WP; Lin CH; Lee TF; Chung MY; Huang CH; Chen SY; Hsueh PR; Chen SC
J Infect; 2020 Sep; 81(3):435-442. PubMed ID: 32553841
[TBL] [Abstract][Full Text] [Related]
5. Detection of SARS-CoV-2-specific antibodies via rapid diagnostic immunoassays in COVID-19 patients.
Chansaenroj J; Yorsaeng R; Posuwan N; Puenpa J; Sudhinaraset N; Chirathaworn C; Poovorawan Y
Virol J; 2021 Mar; 18(1):52. PubMed ID: 33750394
[TBL] [Abstract][Full Text] [Related]
6. Performance evaluation of antibody-based point-of-care devices intended for the identification of immune responses to SARS-CoV-2.
Furuya AKM; Wagner C; Connors J; Bodnar J; Miller T; Ryman NL; Warszycki CJ; Wong SJ; Walsh AC; McDonough KA; Lee WT
Diagn Microbiol Infect Dis; 2021 Apr; 99(4):115298. PubMed ID: 33418405
[TBL] [Abstract][Full Text] [Related]
7. Rapid response flow cytometric assay for the detection of antibody responses to SARS-CoV-2.
Lapuente D; Maier C; Irrgang P; Hübner J; Peter AS; Hoffmann M; Ensser A; Ziegler K; Winkler TH; Birkholz T; Kremer AE; Steininger P; Korn K; Neipel F; Überla K; Tenbusch M
Eur J Clin Microbiol Infect Dis; 2021 Apr; 40(4):751-759. PubMed ID: 33078221
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 Coronavirus Nucleocapsid Antigen-Detecting Half-Strip Lateral Flow Assay Toward the Development of Point of Care Tests Using Commercially Available Reagents.
Grant BD; Anderson CE; Williford JR; Alonzo LF; Glukhova VA; Boyle DS; Weigl BH; Nichols KP
Anal Chem; 2020 Aug; 92(16):11305-11309. PubMed ID: 32605363
[TBL] [Abstract][Full Text] [Related]
9. Head-to-head comparison of two rapid high-throughput automated electrochemiluminescence immunoassays targeting total antibodies to the SARS-CoV-2 nucleoprotein and spike protein receptor binding domain.
Poljak M; Oštrbenk Valenčak A; Štamol T; Seme K
J Clin Virol; 2021 Apr; 137():104784. PubMed ID: 33711693
[TBL] [Abstract][Full Text] [Related]
10. A 10-Minute "Mix and Read" Antibody Assay for SARS-CoV-2.
Rusanen J; Kareinen L; Levanov L; Mero S; Pakkanen SH; Kantele A; Amanat F; Krammer F; Hedman K; Vapalahti O; Hepojoki J
Viruses; 2021 Jan; 13(2):. PubMed ID: 33498157
[TBL] [Abstract][Full Text] [Related]
11. Technical considerations to development of serological tests for SARS-CoV-2.
Ernst E; Wolfe P; Stahura C; Edwards KA
Talanta; 2021 Mar; 224():121883. PubMed ID: 33379092
[TBL] [Abstract][Full Text] [Related]
12. Rapid and Sensitive SERS-Based Lateral Flow Test for SARS-CoV2-Specific IgM/IgG Antibodies.
Srivastav S; Dankov A; Adanalic M; Grzeschik R; Tran V; Pagel-Wieder S; Gessler F; Spreitzer I; Scholz T; Schnierle B; Anastasiou OE; Dittmer U; Schlücker S
Anal Chem; 2021 Sep; 93(36):12391-12399. PubMed ID: 34468139
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 immunochromatographic IgM/IgG rapid test in pregnancy: A false friend?
Fabre M; Ruiz-Martinez S; Monserrat Cantera ME; Cortizo Garrido A; Beunza Fabra Z; Peran M; Benito R; Mateo P; Paules C; Oros D
Ann Clin Biochem; 2021 Mar; 58(2):149-152. PubMed ID: 33242972
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies.
Montesinos I; Gruson D; Kabamba B; Dahma H; Van den Wijngaert S; Reza S; Carbone V; Vandenberg O; Gulbis B; Wolff F; Rodriguez-Villalobos H
J Clin Virol; 2020 Jul; 128():104413. PubMed ID: 32403010
[TBL] [Abstract][Full Text] [Related]
15. Nanoelectrokinetic-assisted lateral flow assay for COVID-19 antibody test.
Kim C; Yoo YK; Lee NE; Lee J; Kim KH; Lee S; Kim J; Park SJ; Lee D; Lee SW; Hwang KS; Han SI; Lee D; Yoon DS; Lee JH
Biosens Bioelectron; 2022 Sep; 212():114385. PubMed ID: 35623254
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of four commercial immunoassays for the detection of antibodies against established SARS-CoV-2 infection.
Chua KYL; Vogrin S; Bittar I; Horvath JH; Wimaleswaran H; Trubiano JA; Holmes NE; Lam Q
Pathology; 2020 Dec; 52(7):778-782. PubMed ID: 33039094
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Two Chemiluminescent and Three ELISA Immunoassays for the Detection of SARS-CoV-2 IgG Antibodies: Implications for Disease Diagnosis and Patients' Management.
Speletas M; Kyritsi MA; Vontas A; Theodoridou A; Chrysanthidis T; Hatzianastasiou S; Petinaki E; Hadjichristodoulou C
Front Immunol; 2020; 11():609242. PubMed ID: 33424863
[TBL] [Abstract][Full Text] [Related]
18. Correlation of SARS-CoV-2 Neutralizing Antibodies to an Automated Chemiluminescent Serological Immunoassay.
Grenache DG; Ye C; Bradfute SB
J Appl Lab Med; 2021 Mar; 6(2):491-495. PubMed ID: 33098417
[TBL] [Abstract][Full Text] [Related]
19. Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech).
Nicol T; Lefeuvre C; Serri O; Pivert A; Joubaud F; Dubée V; Kouatchet A; Ducancelle A; Lunel-Fabiani F; Le Guillou-Guillemette H
J Clin Virol; 2020 Aug; 129():104511. PubMed ID: 32593133
[TBL] [Abstract][Full Text] [Related]
20. Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19.
Chiereghin A; Zagari RM; Galli S; Moroni A; Gabrielli L; Venturoli S; Bon I; Rossini G; Saracino IM; Pavoni M; Lafratta S; Deni A; Felici S; Borghi M; Guerra L; Raumer L; Lodi V; Viale P; Attard L; Lazzarotto T;
Front Public Health; 2020; 8():620222. PubMed ID: 33681115
[No Abstract] [Full Text] [Related]
[Next] [New Search]
